Health Beta: Precision medicine for heart health
Health BETA offers genetic tests and a digital lifestyle therapeutic that help doctors and users identify predisposed heart attack risks and take proactive steps to prevent heart disease.
Coronary artery disease (CAD) prevention is complex due to its multifactorial nature. Inherited and lifestyle-induced risk are the two main factors leading to CAD. Assessing these risk is crucial for effective CAD prevention. However, the current standard of care does not include a genetic assessment to enable very early detection of CAD risk to commence intervention. Additionally, there is a lack of tools to monitor and recommend lifestyle intervention on a daily basis to mitigate CAD risk.
As genes can explain up to 60% of an individual’s risk of CAD, our genetic test can be carried out very early in life to reveal users’ predispositions to the underlying risks that lead to CAD. Our solution will then recommend specific lifestyle interventions to lower the identified risk factors, allowing users to achieve targeted and effective CAD risk reductions.
“Doing a health screening, even once in a few months, is merely identifying disease risk markers. In preventive health, what an individual does on a daily basis largely determines the health outcome. People do not just need to know what is good for their heart health, they need to know specifically how to take action in their daily lives. The advancement in genomics and digital therapeutics have made that possible today.” says A/Prof. Heng Chew Kiat, geneticist at NUS.
“Doing a health screening, even once in a few months, is merely identifying disease risk markers. In preventive health, what an individual does on a daily basis largely determines the health outcome. People do not just need to know what is good for their heart health, they need to know specifically how to take action in their daily lives. The advancement in genomics and digital therapeutics have made that possible today.” says A/Prof. Heng Chew Kiat, geneticist at NUS.
Through genomics and digital therapeutics, we are making precision medicine for heart health possible. 
“Doing a health screening, even once in a few months, is merely identifying disease risk markers. In preventive health, what an individual does on a daily basis largely determines the health outcome. People do not just need to know what is good for their heart health, they need to know specifically how to take action in their daily lives. The advancement in genomics and digital therapeutics have made that possible today.” says A/Prof. Heng Chew Kiat, geneticist at NUS.
Through genomics and digital therapeutics, we are making precision medicine for heart health possible.
Other Related Stories
